A detailed history of Semmax Financial Advisors Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 51,687 shares of MDT stock, worth $4.17 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
51,687
Previous 51,903 0.42%
Holding current value
$4.17 Million
Previous $4.09 Million 13.9%
% of portfolio
1.31%
Previous 1.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.84 - $91.03 $16,597 - $19,662
-216 Reduced 0.42%
51,687 $4.65 Million
Q2 2024

Aug 14, 2024

BUY
$78.71 - $87.02 $223,615 - $247,223
2,841 Added 5.79%
51,903 $4.09 Million
Q1 2024

May 16, 2024

BUY
$82.84 - $88.09 $68,840 - $73,202
831 Added 1.72%
49,062 $4.28 Million
Q4 2023

Feb 14, 2024

BUY
$69.43 - $83.43 $59,432 - $71,416
856 Added 1.81%
48,231 $3.97 Million
Q3 2023

Nov 14, 2023

SELL
$78.22 - $90.4 $169,111 - $195,444
-2,162 Reduced 4.36%
47,375 $3.71 Million
Q4 2022

Feb 09, 2023

BUY
$76.18 - $87.74 $77,398 - $89,143
1,016 Added 2.09%
49,537 $3.98 Million
Q3 2022

Nov 15, 2022

BUY
$80.75 - $95.31 $888,007 - $1.05 Million
10,997 Added 29.31%
48,521 $4.15 Million
Q2 2022

Aug 12, 2022

BUY
$87.4 - $113.09 $509,979 - $659,880
5,835 Added 18.41%
37,524 $3.53 Million
Q1 2022

May 11, 2022

BUY
$100.58 - $112.38 $350,018 - $391,082
3,480 Added 12.34%
31,689 $3.52 Million
Q4 2021

Mar 01, 2022

BUY
$99.53 - $127.75 $2.81 Million - $3.6 Million
28,195 Added 201392.86%
28,209 $2.92 Million
Q2 2019

Aug 07, 2019

SELL
$84.15 - $99.38 $11,360 - $13,416
-135 Reduced 90.6%
14 $1,000
Q1 2019

May 07, 2019

BUY
$82.45 - $93.79 $11,130 - $12,661
135 Added 964.29%
149 $14,000
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $1,201 - $1,392
14 New
14 $1,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $107B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Semmax Financial Advisors Inc. Portfolio

Follow Semmax Financial Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.